Management called order intake unprecedented while revenue grew 1% and cash stayed flat despite $353M of net income.
Thesis: Camtek sits at the inspection and metrology bottleneck for HBM and advanced packaging, where two HBM manufacturers have committed $260M across 2026-2027. The problem is that Q1 revenue grew 1% against 50%+ peer growth while opex grew 26%, AR ballooned 45%, and cash stayed flat. The entire thesis requires a 25% half-on-half revenue step, 450bp margin recovery, and two product lines doubling in the same two quarters. The backlog looks real but the near-term P&L deterioration says the market isn't paying for promises anymore.
Verdict: HOLD — Conviction: MEDIUM
Catalyst: Q2 revenue hitting $130M plus validates the inflection. The HBM $260M converting to recognized revenue starting this quarter. Hawk and Eagle 5G doubling confirms the product cycle. Chiplet IDM account beginning shipments in H2.
Key Risk: The $260M includes forecast dollars Langer declined to split between 2026 and 2027. If the 2026 portion is smaller than investors assume, the 25% H2 surge doesn't land and Q3 guidance gets cut. AR up 45% with flat cash says collections are already slipping.
The Tell: When asked how the $260M HBM commitment splits between 2026 and 2027, Langer stumbled: 'We've not included this in our prepared notes, and I don't want just to be... not to be very accurate. There is a significant number already for 26 shipments and the rest will come in 2027, but there is a big number coming this year.' The non-answer on the split is the tell. If 2026 was the bulk, he'd have said the number. He didn't.
Friction Level: MODERATE_FRICTION — Both sides agree revenue is 1% and peers print 50%. Bull says it's a 1-2 quarter lag behind front-end with orders already banked. Bear says every growth promise is unshipped and forecast dollars aren't bookings. Same facts, opposite read on timing.
Report not found
The report data is no longer available. Please return to the archive.